NCT01286623

Brief Summary

The treatment of HIV and the tests performed for HIV care have changed over the last 20 years. However, improvement of management of HIV-infected subjects is still warranted, especially as the HIV-infected population is aging. Therefore, this study will involve the collection and analysis of clinical information obtained from subjects who are over 50 years of age. For example, patients' risk of heart disease will be measured and monitored by looking at blood tests and clinical data (such as blood pressure). This will allow researchers to understand if the current way of assessing the risk of future heart disease is the best one available for HIV-infected individuals. No genetic research will be done.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 31, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2013

Completed
Last Updated

June 27, 2017

Status Verified

June 1, 2017

Enrollment Period

2.2 years

First QC Date

January 27, 2011

Last Update Submit

June 26, 2017

Conditions

HIV Infection

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV-infected patients over 50 years of age

You may qualify if:

  • The ability to understand and sign a written informed consent form
  • HIV-infected patients attending the Pharmacology/Aging Clinic (HIV/GUM Directorate, Chelsea and Westminster Hospital NHS Foundation Trust)

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Stephen's Centre

London, SW10 9NH, United Kingdom

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Marta Boffito, Dr

    St Stephen's AIDS Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2011

First Posted

January 31, 2011

Study Start

April 1, 2011

Primary Completion

June 6, 2013

Study Completion

June 6, 2013

Last Updated

June 27, 2017

Record last verified: 2017-06

Locations

GB(1)